Article
Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines
18 Jul 2007
Abstract excerpt
Pharmacogenetic studies have shown that several cytochrome P450 (CYP) enzymes exhibit genetic polymorphisms. Several benzodiazepines (BZPs) are metabolized predominantly or partly by polymorphic CYP2C19 and CYP3A4/5. The pharmacokinetics of diazepam, etizolam, quazepam and desmethylclobazam have been shown to be affected by CYP2C19 polymorphism. The CYP3A5 polymorphism has been reported to affect the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
